Cancer Gone Viral: Cell-engineering tackles cancers caused by HPV
TCR HPV Cancer therapy

Cancer Gone Viral: Cell-engineering tackles cancers caused by HPV

Dr. Talia Henkle
Dr. Talia Henkle

In 10 seconds? Researchers are tackling HPV-associated cancers with new, so-called ‘living’ cancer treatments. These engineered T-cell receptors make a patient’s immune cells target HPV proteins in tumors and suppress the cancer.

Hey, I thought the vaccine was successful in preventing HPV-associated cancers? Well, yes, but the vaccine is relatively new so many older people couldn't benefit from it and might have the misfortune of developing an HPV-associated cancer (like cervical, anal, and head and neck cancer). That's why researchers continue the search for better treatments for patients with these cancers.


Get unlimited access to our 3-min Digests and other premium features

Choose your plan:

Personal

$99/year

✅ Includes 7-day free trial for new users
✅ Weekly Recap
✅ Daily newsletter
✅ Access 4 topic areas of your choosing
✅ Access all citations and resources
✅ Gain background knowledge with a Quick Dive
✅ The Sparrow Sessions Podcast
✅ No ads
❌ Direct access to the Expert Network
❌ Your questions - answered by an Expert Scientist
❌ 12 hours of consultations with our fabulous experts per year (that’s 1 hour per month!)
❌ Access to all topic areas as we scale the Content Library

We'll send you a reminder email 3 days before your trial ends.

Start my free trial

Professional

$3499/year

✅ Includes 7-day free trial for new users
✅ Weekly Recap
✅ Daily newsletter
✅ Access all citations and resources
✅ Gain background knowledge with a Quick Dive
✅ The Sparrow Sessions Podcast
✅ No ads
✅ Direct access to the Expert Network
✅ Your questions - answered by an Expert Scientist
✅ 12 hours of consultations with our fabulous experts per year (that’s 1 hour per month!)
✅ Access to all topic areas as we scale the Content Library

We'll send you a reminder email 3 days before your trial ends.

Start my free trial